Invention Application
- Patent Title: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES
-
Application No.: US15163592Application Date: 2016-05-24
-
Publication No.: US20160263216A1Publication Date: 2016-09-15
- Inventor: Barbara BAUDNER , Derek O'HAGAN , Manmohan SINGH , Simone BUFALI
- Applicant: GlaxoSmithKline Biologicals SA
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee: GlaxoSmithKline Biologicals SA
- Current Assignee Address: BE Rixensart
- Main IPC: A61K39/39
- IPC: A61K39/39 ; C12N7/00 ; A61K9/107 ; A61K39/13 ; A61K39/00
Abstract:
The invention improves TdaP vaccines by including a TLR agonist in them. This agonist can provide stronger protection, longer-lasting protection, and/or can reduce the amount of antigen which is required to achieve a particular immune response.
Public/Granted literature
- US09931399B2 Adjuvanted formulations of booster vaccines Public/Granted day:2018-04-03
Information query
